Label-free digital cytopathology using deep-ultraviolet coded ptychography with intrinsic molecular contrast
使用具有内在分子对比的深紫外编码叠层描记术进行无标记数字细胞病理学
基本信息
- 批准号:10718442
- 负责人:
- 金额:$ 36.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvant TherapyAmino AcidsAnatomyAreaBiopsyBrain NeoplasmsBrightfield MicroscopyCell NucleusCellsChemicalsCodeCritical CareCytologyCytopathologyCytoplasmDataDevicesDiagnosisDiseaseDyesElementsEngineeringEvaluationExcisionFine needle aspiration biopsyFluorescenceGlassHealthHistologicHistologyHistopathologyHospitalsHourImageImaging DeviceIndividualInterventionLabelLaboratoriesLightingLungMapsMeasurementMeasuresMedicineMethodsMicroscopeModelingModern MedicineMolecularMorphologyMusNucleic AcidsOperative Surgical ProceduresOpticsPathologistPathologyPatientsPerformancePhasePreparationProcessProteinsQuartzResearch PersonnelResolutionSamplingSignal TransductionSiteSkin NeoplasmsSlideSpecificitySpecimenSpectrum AnalysisStainsSurgical OncologySurgical marginsSystemThickTimeTissue SampleTissuesUltraviolet RaysValidationVariantVisible RadiationWorkabsorptionbiological researchcancer imagingcode developmentcostdata acquisitiondeep neural networkdiffraction of lightdigitalfluorescence microscopehistopathological examinationimmunopathologylensmeterprototypesensorsuccesstooltool developmenttransmission processtumorultravioletvirtual
项目摘要
Project Summary / Abstract
Histopathological examination of tissue is a pillar of modern medicine and biological research. Commonly
used bright-field microscopy requires prior preparation of micrometer-thick tissue sections mounted on glass
slides and stained with dyes, a process that takes hours or days, delaying access to critical information for
interventions. This project aims to develop a new type of high-throughput digital cytopathology tool with
intrinsic molecular contrast for label-free and slide-free histology. This tool will be built based on lensless
high-throughput coded ptychography operated at the 260-nm and 280-nm deep ultraviolet (DUV)
wavelengths. DUV light directly interacts with and is absorbed by biomolecules of nucleic acids (nucleus) and
amino acids (protein) of cells. Absorption spectra are different for these two types of biomolecules. By
measuring the specimen profiles at the 260-nm and 280-nm DUV wavelengths, we can recover the
quantitative mass maps of cell nucleus and protein without any dye labeling. In contrast, there is no
absorption for these biomolecules in the visible light regime.
In the proposed DUV coded ptychography tool, we do not use any optical lens as in a conventional
microscope platform. Instead, we fabricate a disorder-engineered coded layer on top of an image sensor.
This coded layer serves as a large-scale scattering ‘lens’ for imaging specimens placed on top of it. When
light diffracts from the tissue samples at a large angle, the coded layer redirects the diffracted light into
smaller angles that are detectable by sensor pixels. As such, the otherwise inaccessible high-resolution
object details can be acquired using the pixel array underneath the coded layer. Our preliminary data show
that the image throughput is greater than the fastest whole slide scanner in the world: resolving 308-nm
linewidth over a 240-mm2 effective field of view in 15 seconds. By using the dual wavelength DUV LEDs for
sample illumination, the proposed tool will provide both phase-based quantitative morphology measurement
and amplitude-based intrinsic chemical specificities for different biomolecules. It can be used for rapid onsite
evaluation of cytology smear obtained from fine-needle aspirate. It can also reduce sample preparation time
and provides intraoperative pathology guidance on surgical margins. The cost of the entire device will be
similar to that of an iPad, making it a handheld, high-throughput ‘personal’ whole slide scanner for most
individual pathologists and researchers worldwide.
项目总结/摘要
组织的组织学检查是现代医学和生物学研究的支柱。通常
使用的明视野显微镜需要预先制备微米厚的组织切片,
幻灯片和染色,这一过程需要数小时或数天,延迟访问关键信息,
干预措施。本项目旨在开发一种新型的高通量数字化细胞病理学工具,
用于无标记和无载玻片组织学的内在分子对比度。这款工具将基于无透镜
在260 nm和280 nm深紫外(DUV)下操作的高通量编码重叠关联成像
波长DUV光直接与核酸的生物分子(细胞核)相互作用并被其吸收,
细胞的氨基酸(蛋白质)。这两种类型的生物分子的吸收光谱是不同的。通过
在260-nm和280-nm DUV波长下测量样品轮廓,我们可以恢复
没有任何染料标记的细胞核和蛋白质的定量质量图。相比之下,
这些生物分子在可见光区的吸收。
在所提出的DUV编码重叠关联成像工具中,我们不使用任何光学透镜,如在传统的重叠关联成像工具中那样。
显微镜平台相反,我们在图像传感器上制造了一个无序工程编码层。
该编码层用作大尺度散射“透镜”,用于对放置在其上的样本进行成像。
当光以大角度从组织样本衍射时,编码层将衍射光重定向到
传感器像素可检测到的较小角度。因此,其他无法获得的高分辨率
可以使用编码层下面的像素阵列来获取对象细节。我们的初步数据显示
图像吞吐量大于世界上最快的全切片扫描仪:分辨率为308 nm
线宽超过240平方毫米的有效视野在15秒。通过使用双波长DUV LED,
样品照明,建议的工具将提供基于相位的定量形态测量
以及不同生物分子的基于振幅的固有化学特异性。可用于快速现场
细针穿刺细胞学涂片的评价。它还可以减少样品制备时间
并提供手术切缘的术中病理学指导。整个设备的成本将是
类似于iPad,使其成为大多数人的手持,高通量的“个人”全载玻片扫描仪
世界各地的病理学家和研究人员
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guoan Zheng其他文献
Guoan Zheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guoan Zheng', 18)}}的其他基金
Fluorescence ptychographic microscopy for 4D live-cell imaging with high-spatiotemporal resolution and reduced phototoxicity
用于 4D 活细胞成像的荧光叠层照相显微镜,具有高时空分辨率和降低的光毒性
- 批准号:
9332392 - 财政年份:2016
- 资助金额:
$ 36.3万 - 项目类别:
相似海外基金
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 36.3万 - 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
- 批准号:
494901 - 财政年份:2023
- 资助金额:
$ 36.3万 - 项目类别:
Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
- 批准号:
10714537 - 财政年份:2023
- 资助金额:
$ 36.3万 - 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
- 批准号:
10588103 - 财政年份:2023
- 资助金额:
$ 36.3万 - 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
- 批准号:
22K09407 - 财政年份:2022
- 资助金额:
$ 36.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
- 批准号:
21KK0287 - 财政年份:2022
- 资助金额:
$ 36.3万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
- 批准号:
10357120 - 财政年份:2022
- 资助金额:
$ 36.3万 - 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
- 批准号:
21K08700 - 财政年份:2021
- 资助金额:
$ 36.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
- 批准号:
437315 - 财政年份:2020
- 资助金额:
$ 36.3万 - 项目类别:
Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
- 批准号:
435603 - 财政年份:2020
- 资助金额:
$ 36.3万 - 项目类别:
Operating Grants














{{item.name}}会员




